IPC The Hospitalist Company Downgraded to “Hold” at TheStreet (IPCM)
The analysts wrote, “IPC The Hospitalist (IPCM) has been downgraded by TheStreet Ratings from buy to hold. The company’s strengths can be seen in multiple areas, such as its revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, disappointing return on equity and weak operating cash flow.”
Several other analysts have also recently commented on the stock. Analysts at RBC Capital upgraded shares of IPC The Hospitalist Company from a “sector perform” rating to an “outperform” rating in a research note on Friday, June 27th. They now have a $52.00 price target on the stock, up previously from $49.00. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of IPC The Hospitalist Company in a research note on Wednesday, June 18th. They now have a $42.00 price target on the stock, down previously from $50.00. Finally, analysts at Wells Fargo & Co. upgraded shares of IPC The Hospitalist Company from a “market perform” rating to an “outperform” rating in a research note on Friday, April 25th. Eight research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $52.22.
Shares of IPC The Hospitalist Company (NASDAQ:IPCM) traded up 1.27% on Wednesday, hitting $47.00. 102,119 shares of the company’s stock traded hands. IPC The Hospitalist Company has a 52-week low of $38.13 and a 52-week high of $63.70. The stock’s 50-day moving average is $42.51 and its 200-day moving average is $48.76. The company has a market cap of $805.2 million and a P/E ratio of 19.67.
IPC The Hospitalist Company (NASDAQ:IPCM) last released its earnings data on Wednesday, April 23rd. The company reported $0.57 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.64 by $0.07. The company had revenue of $172.73 million for the quarter, compared to the consensus estimate of $183.00 million. During the same quarter last year, the company posted $0.57 earnings per share. IPC The Hospitalist Company’s revenue was up 12.8% compared to the same quarter last year. On average, analysts predict that IPC The Hospitalist Company will post $2.40 earnings per share for the current fiscal year.
IPC The Hospitalist Company, Inc (NASDAQ:IPCM) is a provider of hospitalist services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.